Quadcap Wealth Management, LLC
Source: SEC Form 13F · as of Mar 2026Quadcap Wealth Management, LLC holds 25 biotech & pharma companies tracked by BioSniper, totaling $21.0M in value as of Mar 2026 (SEC Form 13F).
Companies held
25
Total value held
$21.0M
| Company | Shares | Value |
|---|---|---|
| JNJJOHNSON & JOHNSON | 14,265 | $3.5M |
| ABBVAbbVie Inc. | 11,966 | $2.6M |
| NVSNovartis AG | 15,367 | $2.3M |
| LLYELI LILLY & Co | 1,790 | $1.6M |
| MRKMerck & Co., Inc. | 12,558 | $1.5M |
| PMPhilip Morris International Inc | 7,820 | $1.3M |
| MCKMcKesson Corporation | 1,316 | $1.1M |
| BMYBRISTOL MYERS SQUIBB CO | 18,578 | $1.1M |
| ABTABBOTT LABORATORIES | 8,269 | $849K |
| VRTXVERTEX PHARMACEUTICALS INC / MA | 1,891 | $844K |
| GILDGILEAD SCIENCES, INC. | 4,918 | $685K |
| PFEPFIZER INC | 23,766 | $667K |
| UNHUnitedHealth Group Incorporated Common Stock (DE) | 2,060 | $557K |
| CORCencora Inc. | 1,054 | $331K |
| ZTSZoetis Inc. | 2,664 | $315K |
| GEHCGE HealthCare Technologies Inc. | 3,644 | $259K |
| AMGNAMGEN INC | 726 | $255K |
| ALNYALNYLAM PHARMACEUTICALS, INC. | 707 | $234K |
| CRSPCRISPR Therapeutics AG | 4,840 | $230K |
| GPCRStructure Therapeutics Inc. | 4,729 | $228K |
| DGXQuest Diagnostics Incorporated | 1,095 | $215K |
| REPLReplimune Group, Inc. | 10,000 | $77K |
| OVIDOvid Therapeutics Inc. | 15,111 | $34K |
| CLOVClover Health Investments Corp. | 10,000 | $18K |
| TNYATenaya Therapeutics, Inc. | 10,000 | $7K |
13F holdings reflect long positions in U.S.-listed securities as reported to the SEC. Values are point-in-time for the most recent reported quarter.